Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × GSK 1363089 × Clear all

NCT01138384 2023-08-04

Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer

Phase 1/2 Completed

Breast Neoplasms